Literature DB >> 20683852

Defining process design space for a hydrophobic interaction chromatography (HIC) purification step: application of quality by design (QbD) principles.

Canping Jiang1, Lisa Flansburg, Sanchayita Ghose, Paul Jorjorian, Abhinav A Shukla.   

Abstract

The concept of design space has been taking root under the quality by design paradigm as a foundation of in-process control strategies for biopharmaceutical manufacturing processes. This paper outlines the development of a design space for a hydrophobic interaction chromatography (HIC) process step. The design space included the impact of raw material lot-to-lot variability and variations in the feed stream from cell culture. A failure modes and effects analysis was employed as the basis for the process characterization exercise. During mapping of the process design space, the multi-dimensional combination of operational variables were studied to quantify the impact on process performance in terms of yield and product quality. Variability in resin hydrophobicity was found to have a significant influence on step yield and high-molecular weight aggregate clearance through the HIC step. A robust operating window was identified for this process step that enabled a higher step yield while ensuring acceptable product quality.
© 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20683852     DOI: 10.1002/bit.22894

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  5 in total

1.  Toward QbD Process Understanding on DNA Vaccine Purification Using Design of Experiment.

Authors:  Lalintip Hocharoen; Sarawuth Noppiboon; Panit Kitsubun
Journal:  Front Bioeng Biotechnol       Date:  2021-05-12

2.  Purification of monoclonal antibodies by hydrophobic interaction chromatography under no-salt conditions.

Authors:  Sanchayita Ghose; Yinying Tao; Lynn Conley; Douglas Cecchini
Journal:  MAbs       Date:  2013-06-26       Impact factor: 5.857

3.  Specification-driven acceptance criteria for validation of biopharmaceutical processes.

Authors:  Lukas Marschall; Christopher Taylor; Thomas Zahel; Marco Kunzelmann; Alexander Wiedenmann; Beate Presser; Joey Studts; Christoph Herwig
Journal:  Front Bioeng Biotechnol       Date:  2022-09-23

Review 4.  Sophisticated Cloning, Fermentation, and Purification Technologies for an Enhanced Therapeutic Protein Production: A Review.

Authors:  Sanjeev K Gupta; Pratyoosh Shukla
Journal:  Front Pharmacol       Date:  2017-07-04       Impact factor: 5.810

5.  A Novel Framework to Aid the Development of Design Space across Multi-Unit Operation Pharmaceutical Processes-A Case Study of Panax Notoginseng Saponins Immediate Release Tablet.

Authors:  Fei Sun; Bing Xu; Shengyun Dai; Yi Zhang; Zhaozhou Lin; Yanjiang Qiao
Journal:  Pharmaceutics       Date:  2019-09-13       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.